Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.3 USD | +4.46% | +10.55% | -34.24% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.24% | 824M | |
-2.58% | 103B | |
+1.37% | 95.28B | |
+1.75% | 22.15B | |
-15.67% | 21.02B | |
-8.19% | 18.15B | |
-41.01% | 16.73B | |
-13.43% | 16.05B | |
+4.13% | 13.68B | |
+34.55% | 12.17B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Deutsche Bank Adjust Sage Therapeutics Price Target to $18 From $21, Maintains Hold Rating